Net Income Common - Calithera Biosciences Inc (OTC:CALA) - Alpha Spread
C

Calithera Biosciences Inc
OTC:CALA

Watchlist Manager
Calithera Biosciences Inc
OTC:CALA
Watchlist
Price: 0.02 USD Market Closed
Market Cap: 97.5k USD
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Calithera Biosciences Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calithera Biosciences Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
C
Calithera Biosciences Inc
F:2CB
Net Income (Common)
-$21.3m
CAGR 3-Years
38%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.3B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$1.1B
CAGR 3-Years
-41%
CAGR 5-Years
-29%
CAGR 10-Years
-18%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Calithera Biosciences Inc's Net Income (Common)?
Net Income (Common)
-21.3m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Net Income (Common) amounts to -21.3m USD.

What is Calithera Biosciences Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
5%

Over the last year, the Net Income (Common) growth was 82%. The average annual Net Income (Common) growth rates for Calithera Biosciences Inc have been 38% over the past three years , 5% over the past five years .

Back to Top